Selected research
Industry Research
Ion Exchange Ligand Industry Research Report 2026
Market perspective
The global Ion Exchange Ligand market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ion Exchange Ligand is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ion Exchange Ligand is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ion Exchange Ligand is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ion Exchange Ligand include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ion Exchange Ligand market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Ion Exchange Ligand.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ion Exchange Ligand Market by Company
Merck
Thermo Fisher
Purolite
Sartorius
JNC
Sunresin
Agarose Bead Technologies
NanoMicro
VDO Biotech
Cytiva
Tosoh Bioscience
Bio-Rad
Ion Exchange Ligand Segment by Type
Anion Exchange Ligand
Cation Exchange Ligand
Mixed-Mode Ion Exchange Ligand
Ion Exchange Ligand Segment by Application
Monoclonal Antibody Purification
Recombinant Protein Purification
Vaccine and Viral Vector Purification
Nucleic Acid Purification
Impurity Removal
Analytical Sample Preparation
Ion Exchange Ligand Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ion Exchange Ligand market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ion Exchange Ligand and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ion Exchange Ligand.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ion Exchange Ligand manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ion Exchange Ligand by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ion Exchange Ligand in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anion Exchange Ligand
- Cation Exchange Ligand
- Mixed-Mode Ion Exchange Ligand
Applications
- Monoclonal Antibody Purification
- Recombinant Protein Purification
- Vaccine and Viral Vector Purification
- Nucleic Acid Purification
- Impurity Removal
- Analytical Sample Preparation
Companies covered
- Merck
- Thermo Fisher
- Purolite
- Sartorius
- JNC
- Sunresin
- Agarose Bead Technologies
- NanoMicro
- VDO Biotech
- Cytiva
- Tosoh Bioscience
- Bio-Rad
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Ion Exchange Ligand by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Anion Exchange Ligand
- 2.2.3 Cation Exchange Ligand
- 2.2.4 Mixed-Mode Ion Exchange Ligand
- 2.3 Ion Exchange Ligand by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Monoclonal Antibody Purification
- 2.3.3 Recombinant Protein Purification
- 2.3.4 Vaccine and Viral Vector Purification
- 2.3.5 Nucleic Acid Purification
- 2.3.6 Impurity Removal
- 2.3.7 Analytical Sample Preparation
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Ion Exchange Ligand Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Ion Exchange Ligand Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Ion Exchange Ligand Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Ion Exchange Ligand Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ion Exchange Ligand Production by Manufacturers (2021-2026)
- 3.2 Global Ion Exchange Ligand Production Value by Manufacturers (2021-2026)
- 3.3 Global Ion Exchange Ligand Average Price by Manufacturers (2021-2026)
- 3.4 Global Ion Exchange Ligand Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ion Exchange Ligand Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Ion Exchange Ligand Manufacturers, Product Type & Application
- 3.7 Global Ion Exchange Ligand Manufacturers Established Date
- 3.8 Global Ion Exchange Ligand Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Ion Exchange Ligand Company Information
- 4.1.2 Merck Ion Exchange Ligand Business Overview
- 4.1.3 Merck Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Merck Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 Thermo Fisher
- 4.2.1 Thermo Fisher Ion Exchange Ligand Company Information
- 4.2.2 Thermo Fisher Ion Exchange Ligand Business Overview
- 4.2.3 Thermo Fisher Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Product Portfolio
- 4.2.5 Thermo Fisher Recent Developments
- 4.3 Purolite
- 4.3.1 Purolite Ion Exchange Ligand Company Information
- 4.3.2 Purolite Ion Exchange Ligand Business Overview
- 4.3.3 Purolite Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Purolite Product Portfolio
- 4.3.5 Purolite Recent Developments
- 4.4 Sartorius
- 4.4.1 Sartorius Ion Exchange Ligand Company Information
- 4.4.2 Sartorius Ion Exchange Ligand Business Overview
- 4.4.3 Sartorius Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Sartorius Product Portfolio
- 4.4.5 Sartorius Recent Developments
- 4.5 JNC
- 4.5.1 JNC Ion Exchange Ligand Company Information
- 4.5.2 JNC Ion Exchange Ligand Business Overview
- 4.5.3 JNC Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 JNC Product Portfolio
- 4.5.5 JNC Recent Developments
- 4.6 Sunresin
- 4.6.1 Sunresin Ion Exchange Ligand Company Information
- 4.6.2 Sunresin Ion Exchange Ligand Business Overview
- 4.6.3 Sunresin Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Sunresin Product Portfolio
- 4.6.5 Sunresin Recent Developments
- 4.7 Agarose Bead Technologies
- 4.7.1 Agarose Bead Technologies Ion Exchange Ligand Company Information
- 4.7.2 Agarose Bead Technologies Ion Exchange Ligand Business Overview
- 4.7.3 Agarose Bead Technologies Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Agarose Bead Technologies Product Portfolio
- 4.7.5 Agarose Bead Technologies Recent Developments
- 4.8 NanoMicro
- 4.8.1 NanoMicro Ion Exchange Ligand Company Information
- 4.8.2 NanoMicro Ion Exchange Ligand Business Overview
- 4.8.3 NanoMicro Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 NanoMicro Product Portfolio
- 4.8.5 NanoMicro Recent Developments
- 4.9 VDO Biotech
- 4.9.1 VDO Biotech Ion Exchange Ligand Company Information
- 4.9.2 VDO Biotech Ion Exchange Ligand Business Overview
- 4.9.3 VDO Biotech Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 VDO Biotech Product Portfolio
- 4.9.5 VDO Biotech Recent Developments
- 4.10 Cytiva
- 4.10.1 Cytiva Ion Exchange Ligand Company Information
- 4.10.2 Cytiva Ion Exchange Ligand Business Overview
- 4.10.3 Cytiva Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Cytiva Product Portfolio
- 4.10.5 Cytiva Recent Developments
- 4.11 Tosoh Bioscience
- 4.11.1 Tosoh Bioscience Ion Exchange Ligand Company Information
- 4.11.2 Tosoh Bioscience Ion Exchange Ligand Business Overview
- 4.11.3 Tosoh Bioscience Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Tosoh Bioscience Product Portfolio
- 4.11.5 Tosoh Bioscience Recent Developments
- 4.12 Bio-Rad
- 4.12.1 Bio-Rad Ion Exchange Ligand Company Information
- 4.12.2 Bio-Rad Ion Exchange Ligand Business Overview
- 4.12.3 Bio-Rad Ion Exchange Ligand Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Bio-Rad Product Portfolio
- 4.12.5 Bio-Rad Recent Developments
5 Global Ion Exchange Ligand Production by Region
- 5.1 Global Ion Exchange Ligand Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ion Exchange Ligand Production by Region: 2021-2032
- 5.2.1 Global Ion Exchange Ligand Production by Region: 2021-2026
- 5.2.2 Global Ion Exchange Ligand Production Forecast by Region (2027-2032)
- 5.3 Global Ion Exchange Ligand Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Ion Exchange Ligand Production Value by Region: 2021-2032
- 5.4.1 Global Ion Exchange Ligand Production Value by Region: 2021-2026
- 5.4.2 Global Ion Exchange Ligand Production Value Forecast by Region (2027-2032)
- 5.5 Global Ion Exchange Ligand Market Price Analysis by Region (2021-2026)
- 5.6 Global Ion Exchange Ligand Production and Value, YOY Growth
- 5.6.1 North America Ion Exchange Ligand Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Ion Exchange Ligand Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Ion Exchange Ligand Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Ion Exchange Ligand Production Value Estimates and Forecasts (2021-2032)
6 Global Ion Exchange Ligand Consumption by Region
- 6.1 Global Ion Exchange Ligand Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ion Exchange Ligand Consumption by Region (2021-2032)
- 6.2.1 Global Ion Exchange Ligand Consumption by Region: 2021-2026
- 6.2.2 Global Ion Exchange Ligand Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ion Exchange Ligand Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ion Exchange Ligand Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ion Exchange Ligand Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ion Exchange Ligand Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ion Exchange Ligand Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ion Exchange Ligand Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Ion Exchange Ligand Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Ion Exchange Ligand Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Ion Exchange Ligand Production by Type (2021-2032)
- 7.1.1 Global Ion Exchange Ligand Production by Type (2021-2032) & (t)
- 7.1.2 Global Ion Exchange Ligand Production Market Share by Type (2021-2032)
- 7.2 Global Ion Exchange Ligand Production Value by Type (2021-2032)
- 7.2.1 Global Ion Exchange Ligand Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Ion Exchange Ligand Production Value Market Share by Type (2021-2032)
- 7.3 Global Ion Exchange Ligand Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Ion Exchange Ligand Production by Application (2021-2032)
- 8.1.1 Global Ion Exchange Ligand Production by Application (2021-2032) & (t)
- 8.1.2 Global Ion Exchange Ligand Production Market Share by Application (2021-2032)
- 8.2 Global Ion Exchange Ligand Production Value by Application (2021-2032)
- 8.2.1 Global Ion Exchange Ligand Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Ion Exchange Ligand Production Value Market Share by Application (2021-2032)
- 8.3 Global Ion Exchange Ligand Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Ion Exchange Ligand Value Chain Analysis
- 9.1.1 Ion Exchange Ligand Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Ion Exchange Ligand Production Mode & Process
- 9.2 Ion Exchange Ligand Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ion Exchange Ligand Distributors
- 9.2.3 Ion Exchange Ligand Customers
10 Global Ion Exchange Ligand Analyzing Market Dynamics
- 10.1 Ion Exchange Ligand Industry Trends
- 10.2 Ion Exchange Ligand Industry Drivers
- 10.3 Ion Exchange Ligand Industry Opportunities and Challenges
- 10.4 Ion Exchange Ligand Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst